MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 140 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,413,400 | -63.1% | 85,000 | -41.6% | 3.49% | -70.3% |
| Q2 2023 | $33,633,600 | +49.3% | 145,600 | +56.6% | 11.75% | +58.0% |
| Q1 2023 | $22,530,180 | +10.9% | 93,000 | +32.9% | 7.44% | -6.7% |
| Q4 2022 | $20,317,500 | +78.6% | 70,000 | -60.0% | 7.97% | +151.0% |
| Q3 2022 | $11,373,000 | +58.9% | 175,000 | +75.0% | 3.17% | +5.2% |
| Q2 2022 | $7,158,000 | -2.7% | 100,000 | +33.3% | 3.02% | +156.3% |
| Q1 2022 | $7,359,000 | +33.6% | 75,000 | +15.4% | 1.18% | -41.2% |
| Q4 2021 | $5,508,000 | +890.6% | 65,000 | +1200.0% | 2.00% | +578.0% |
| Q4 2020 | $556,000 | – | 5,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |